Songjiang Ma, President at GYRE THERAPEUTICS, INC. (GYRE), sold 2,558 shares at $10.07 ($26K) on 2025-05-28, disclosed to the SEC on 2025-05-29.
Scheduled sale ($26k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.28 | 2,000 | $21K | 78.5% |
| 2 | $10.07 | 558 | $6K | 21.5% |
| Total | $10.23 avg | 2,558 | $26K | 100% |
| Filing → |
| GYRE | SELL | 2025-05-20 | $45K | — | Filing → |
| GYRE | SELL | 2025-05-16 | $22K | — | Filing → |
| GYRE | SELL | 2025-05-14 | $44K | — | Filing → |